Interventional radiologists in Italy have shown the feasibility of concurrent radio-frequency ablation of hepatic and pulmonary tumors.
Interventional radiologists in Italy have shown the feasibility of concurrent radio-frequency ablation of hepatic and pulmonary tumors.
Dr. Davide Becanni and colleagues at the University of Florence performed 65 RF ablations in 25 patients with hepatic and pulmonary metastases from colorectal carcinoma. Both hepatic and pulmonary lesions were treated in a single-session procedure using one RF generator with either single or cluster probes. RFA successfully ablated all lesions, as confirmed by either CT or PET follow-up.
No liver complications were reported, although five patients who were treated for pulmonary metastases developed pneumothorax.
Physicians still have to define the best target population and the cost-benefit ratio for dual RFA. But his study shows that the procedure can reduce hospitalization time without adding to the complication rate, Becanni said.
Comparative AI Study Shows Merits of RapidAI LVO Software in Stroke Detection
February 6th 2025The Rapid LVO AI software detected 33 percent more cases of large vessel occlusion (LVO) on computed tomography angiography (CTA) than Viz LVO AI software, according to a new comparative study presented at the International Stroke Conference (ISC).
What a New Meta-Analysis Reveals About PET/CT Radiotracers for csPCa
February 6th 2025The PET/CT agent 18F-PSMA-1007 offered the highest surface under the cumulative ranking curve (SUCRA) out of nine radiotracers at the patient and lesion level for detecting clinically significant prostate cancer (csPCa), according to a meta-analysis.